Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Viread in Inactive Chronic Hepatitis B
NCT02600117Phase 3Completed
- Sponsor
- University Health Network
- Start
- Jan 2016
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tenofovir disoproxil fumarate in Chronic Hepatitis B (CHB), sponsored by University Health Network. Started Jan 2016; status: completed.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT02600117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02600117.